Coverage
-
October 07, 2015
A Colorado federal judge Wednesday tossed a proposed class action filed by a patient with Gaucher disease accusing drugmaker Genzyme Corp. of replacing his injection treatments with an ineffective drug that advanced his condition, concurring with a magistrate judge that the complaint was "convoluted."
2 other articles on this case.
View all »